Understanding the European Stance: Why is Ozempic Banned in Europe (for Weight Loss)?
•
4 min read
Contrary to sensational headlines, Ozempic (semaglutide) is not banned in Europe; it has been approved since 2018 for treating type 2 diabetes. The misconception stems from restrictions and temporary bans imposed by several European countries specifically targeting its off-label use for weight loss, a response to severe supply shortages threatening diabetic patients.
